PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
59.87
Similar ESG score to RIGL's 60.88. Bruce Berkowitz would investigate if industry ESG norms adequately address regulatory risks.
50.00
Environmental score 80-90% of RIGL's 59.76. Walter Schloss would scrutinize carbon exposure and transition planning.
61.14
Social score 90-95% of RIGL's 65.58. Bill Ackman would demand clear social improvement catalysts.
68.48
Governance score 1.1-1.2x RIGL's 57.30. Guy Spier would verify if superior governance translates to better capital allocation and strategic execution.